-
Product Insights
NewInterleukin 23 Receptor – Drugs In Development, 2024
The Interleukin 23 Receptor pipeline drugs market research report outlays comprehensive information on the Interleukin 23 Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Gastrointestinal, Infectious Disease, and Musculoskeletal Disorders which include indications of Psoriasis, Plaque Psoriasis (Psoriasis Vulgaris), Crohn's Disease (Regional Enteritis), Colitis, Coronavirus Disease 2019 (COVID-19), and Psoriatic Arthritis. It also reviews key...
-
Product Insights
NewMAP Kinase Activated Protein Kinase 2 – Drugs In Development, 2024
The MAP Kinase Activated Protein Kinase 2 pipeline drugs market research report outlays comprehensive information on the MAP Kinase Activated Protein Kinase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Musculoskeletal Disorders, Oncology, Immunology, and Respiratory which include indications of Ankylosing Spondylitis (Bekhterev's Disease), Psoriatic Arthritis, Bladder Cancer, Head And Neck Cancer, Rheumatoid Arthritis, and Acute...
-
Product Insights
NewcAMP Specific 3′,5′ Cyclic Phosphodiesterase 4B – Drugs In Development, 2024
The cAMP Specific 3',5' Cyclic Phosphodiesterase 4B pipeline drugs market research report outlays comprehensive information on the cAMP Specific 3',5' Cyclic Phosphodiesterase 4B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Central Nervous System, Musculoskeletal Disorders, and Immunology which include indications of Respiratory, Asthma, Schizophrenia, Unspecified Neurologic Disorders, Psoriatic Arthritis, Plaque Psoriasis (Psoriasis Vulgaris), and Palmoplantar...
-
Product Insights
NewInterleukin 17F – Drugs In Development, 2024
The Interleukin 17F pipeline drugs market research report outlays comprehensive information on the Interleukin 17F targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Musculoskeletal Disorders, Dermatology, and Undisclosed which include indications of Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis, Ankylosing Spondylitis (Bekhterev's Disease), Psoriatic Arthritis, Hidradenitis Suppurativa, Atopic Dermatitis (Atopic Eczema), and Unspecified. It also reviews key players...
-
Product Insights
NewInterleukin 23 – Drugs In Development, 2024
The Interleukin 23 pipeline drugs market research report outlays comprehensive information on the Interleukin 23 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Gastrointestinal, Musculoskeletal Disorders, and Dermatology which include indications of Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis, Crohn's Disease (Regional Enteritis), Ulcerative Colitis, Psoriatic Arthritis, Axial Spondyloarthritis, Hidradenitis Suppurativa, and Dermatological Disorders. It also reviews key...
-
Product Insights
NewInterleukin 17 – Drugs In Development, 2024
The Interleukin 17 pipeline drugs market research report outlays comprehensive information on the Interleukin 17 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Musculoskeletal Disorders, Dermatology, and Oncology which include indications of Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis, Ankylosing Spondylitis (Bekhterev's Disease), Psoriatic Arthritis, Hidradenitis Suppurativa, Pruritus, Oncology, and Colorectal Cancer. It also reviews key players involved...
-
Product Insights
NewLymphotoxin Alpha – Drugs In Development, 2024
The Lymphotoxin Alpha pipeline drugs market research report outlays comprehensive information on the Lymphotoxin Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Musculoskeletal Disorders, Gastrointestinal, and Infectious Disease which include indications of Rheumatoid Arthritis, Plaque Psoriasis (Psoriasis Vulgaris), Ankylosing Spondylitis (Bekhterev's Disease), Psoriatic Arthritis, Ulcerative Colitis, and Coronavirus Disease 2019 (COVID-19). It also reviews key...
-
Product Insights
NewInterleukin 17A – Drugs In Development, 2024
The Interleukin 17A pipeline drugs market research report outlays comprehensive information on the Interleukin 17A targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Musculoskeletal Disorders, Dermatology, and Ophthalmology which include indications of Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis, Ankylosing Spondylitis (Bekhterev's Disease), Psoriatic Arthritis, Hidradenitis Suppurativa, Atopic Dermatitis (Atopic Eczema), Uveitis, and Graves' Ophthalmopathy. It also reviews...
-
Product Insights
NewInterleukin 23 Subunit Alpha – Drugs In Development, 2024
The Interleukin 23 Subunit Alpha pipeline drugs market research report outlays comprehensive information on the Interleukin 23 Subunit Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Gastrointestinal, Musculoskeletal Disorders, and Dermatology which include indications of Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis, Ulcerative Colitis, Crohn's Disease (Regional Enteritis), Psoriatic Arthritis, Axial Spondyloarthritis, Hidradenitis Suppurativa, and Atopic Dermatitis...
-
Product Insights
NewInterleukin 12 Subunit Beta – Drugs In Development, 2024
The Interleukin 12 Subunit Beta pipeline drugs market research report outlays comprehensive information on the Interleukin 12 Subunit Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Gastrointestinal, Musculoskeletal Disorders, and Oncology which include indications of Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis, Ulcerative Colitis, Crohn's Disease (Regional Enteritis), Psoriatic Arthritis, Axial Spondyloarthritis, Ovarian Cancer, and Prostate Cancer....
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.